FDA's "new model" for PMAs/IDEs
This article was originally published in The Gray Sheet
Executive Summary
90-day comment period begins July 21 for the agency's June guidance document offering manufacturers the choice of expedited, streamlined or standard routes for submissions ("The Gray Sheet" June 22, p. 10)